Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

ICAgen and Children's Hospital of Boston to develop novel therapeutics

March 28, 2000

Promising phase I/II results reported by Collateral for Generx

March 28, 2000

Dual ACAT-inhibitory/antioxidant effects of KY-455 may be advantageous in atherosclerosis

March 27, 2000

BASF describes new endothelin receptor antagonists and their use

March 27, 2000

Depression and anxiety, significant risk factors for hypertension

March 27, 2000

The novel antiarrhythmic agent NIP-142 may act by blocking open Kv1.5 potassium channels

March 24, 2000

CV Therapeutics commences second phase II clinical trial for CVT-510

March 24, 2000

NO donor FK-409 protects against postischemic myocardial dysfunction in Langendorff hearts

March 24, 2000

E-5564 proves safe and effective in humans with experimentally induced endotoxemia

March 23, 2000

Coreg trial stopped early due to positive results

March 22, 2000

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...